openPR Logo
Press release

Alzheimer’s Association Long Island Releases “2011 Alzheimer’s Facts and Figures” Report

04-12-2011 07:58 AM CET | Associations & Organizations

Press release from: Alzheimer’s Association Long Island

/ PR Agency: PRMG
"2011 Alzheimer's Facts and Figures" Report

"2011 Alzheimer's Facts and Figures" Report

Ronkonkoma, NY — Alzheimer’s Association Long Island released its “2011 Alzheimer’s Disease Facts and Figures” report, which this year included a special section on early detection and diagnosis of Alzheimer’s.

According to the report, there are an estimated 14.9 million unpaid caregivers who are providing care to 5.4 million people with Alzheimer’s disease. In addition, Alzheimer’s disease costs the American healthcare system $183 billion annually.

“2011 Alzheimer’s Disease Facts and Figures” provides a statistical resource for U.S. data related to Alzheimer’s disease, the most common type of dementia, as well as other dementias. This information includes definitions of the types of dementia and a summary of current knowledge about Alzheimer’s disease. Additional sections address prevalence, mortality, caregiving and use and costs of care and services. The Special Report focuses on the benefits and challenges of early detection and diagnosis of Alzheimer’s disease.

Alzheimer’s disease is the most common type of dementia which accounts for an estimated 60-80% of all dementia cases, according to the report. Early symptoms of Alzheimer’s are difficulty remembering names and recent events, apathy and depression. Later symptoms include impaired judgment, disorientation, confusion, changes in behavior and difficulty speaking, swallowing and walking.

An estimated 5.4 million Americans have Alzheimer’s disease, according to the report. Of that number, 5.2 million are 65 years of age and older. That means one in eight people aged 65 and older have Alzheimer’s. The report further says that from 2000 to 2008, the number of deaths related to Alzheimer’s increased 66%. In New York State, an estimated 320,000 residents were afflicted with Alzheimer’s, with 1,999 deaths attributed to Alzheimer’s. It is estimated that, by 2025, there will be 350,000 New Yorkers afflicted with Alzheimer’s.

The report also showed that nearly 15 million Americans provide unpaid care for a person with Alzheimer’s or another dementia and 80% of that care provided at home is delivered by family caregivers. In 2010, these caregivers provided 17 billion hours in unpaid care at a value of more than $202 billion. New York State has 990,490 people caring for those with Alzheimer’s and dementia. These caregivers perform more than 1.1 billion hours of unpaid care per year at an annual value of more than $13.4 billion.

Nationwide, caring for those with Alzheimer’s and other dementia costs $183 billion, with Medicare paying 51% of the cost at $93 billion, followed by Medicaid (20% at $37 billion), out of pocket (17% at $31 billion) and other sources (12% at $22 billion). The cost is expected to increase to $1.1 trillion by 2050. Most Alzheimer’s patients are hospitalized because of falls, ischemic heart disease, gastrointestinal disease, pneumonia and delirium or change in mental status.

As a result of caring for those with Alzheimer’s, many caregivers who are employed have had to switch jobs, work fewer hours or quit their jobs. In 2010, more than 6 in 10 caregivers reported high or very high levels of emotional stress and another 41% reporting physical stress. Many had to go to the emergency room for these symptoms, resulting in $7.9 billion in healthcare costs. About one-third of caregivers reported signs of depression.

“We have recognized the enormous financial and emotional toll on those caring for a loved one with Alzheimer’s,” says Mary Ann Malack-Ragona, Executive Director/CEO, Alzheimer’s Association Long Island. “These caregivers want to care for their loved ones at home as long as possible, keeping them out of assisted living facilities and nursing homes. Providing additional incentives for families and increased availability of home health aides can greatly reduce healthcare costs.”

The special report discusses the benefits and challenges of early diagnosis and detection of Alzheimer’s and other forms of dementia. While brain imaging techniques and the use of biomarkers can help investigate the causes of cognitive dysfunction, the report says they are not reliable techniques for diagnosing Alzheimer’s.

“This report is a valuable asset for those who wish to know more about Alzheimer’s disease and the effect it has not just on those with Alzheimer’s, but on their families and the caregivers,” Ms. Malack-Ragona says. “Early detection of Alzheimer’s or other dementia is crucial. Any delay may result in the advancement of the disease, which will greatly reduce the quality of life for that person. They say up to 80% of those afflicted with the disease are never diagnosed. If someone you love shows a change in behavior, I urge you to have that person undergo detection for Alzheimer’s or dementia.”

For more information about the Alzheimer’s Association, please contact Mary Ann Malack-Ragona at (631) 820-8068 or visit us at www.alz.org/longisland.

###

* Picture is attached and available upon request.
** Copies of the report are available upon request.

Hank Russell, Public Relations Director
PRMG
156 North Ocean Avenue
Patchogue, NY 11772
631-207-1057
hrussell@theprmg.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Alzheimer’s Association Long Island Releases “2011 Alzheimer’s Facts and Figures” Report here

News-ID: 170545 • Views:

More Releases from Alzheimer’s Association Long Island

Sunrise Senior Living Bowls for a Cause to Benefit Alzheimer’s Association Lon …
Sunrise Senior Living in West Babylon is spearheading a bowling event for the rest of the Sunrise communities that will take place November 3 at 300 Long Island, 895 Walt Whitman Road in Melville, from 1-3 p.m. The event will raise money for Alzheimer’s Association Long Island. The cost is $25 per person, which includes shoe rental, a slice of pizza, soda and two hours of bowling. All proceeds will be
Alzheimer’s Association Long Island and NYC Chapters Present Public Input Sess …
On August 18, the Alzheimer’s Association Long Island Chapter will join the New York City chapter in holding a public input session to solicit views, comments and perspectives from stakeholders in the Alzheimer’s community to assist with the development of a successful National Alzheimer’s Plan. The recommendations and comments expressed during these input sessions, taking place across the country in August, will be collected and shared this fall with officials
Last Chance for Walkers to Register for 2011 Walk to End Alzheimer’s
Alzheimer’s Association Long Island is reminding all walkers to register for the2011 Walk to End Alzheimer’s/Oktoberfest, if they have not already done so. The walk will take place September 10 at Old Bethpage Village Restoration, 1303 Round Swamp Road, Old Bethpage. This is a 5-kilometer (3.1-mile) walk and will be held rain or shine. Although participants can register individually, team registration is crucial for the organization to reach its goal this
Bankers Conseco Life Insurance Company Presents 9th Annual Forget Me Not Days Fu …
Ronkonkoma, NY — Alzheimer’s Association Long Island has announced that Bankers Conseco Life Insurance Company is hosting its Ninth Annual Forget Me Not Days fundraiser, which will be taking place May 13-14. Employees from Bankers Conseco’s Islandia branch will be wearing distinctive green aprons and collecting donations for Alzheimer’s Association Long Island at three separate locations: ● Ace Hardware, 3606 Veterans Highway, Bohemia (May 13-14, 9 a.m.-4 p.m.) ● Waldbaum’s, 4054 Nesconset

All 5 Releases


More Releases for Alzheimer

Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is
Anti-β-Alzheimer Therapies Market : Consumption, Revenue, Applications With Maj …
Alzheimer disease (AD) is a type of dementia that affects memory, thinking, language and behavior. Increasing age and high number of people suffering from Alzheimer's with age 65 and older are the major risk factors for progression of this disorder. It starts with mild symptoms and ends with severe brain damage in which individuals lose the ability to carry on a conversation and respond to their environment. According to Alzheimer
Anti-β-Alzheimer Therapies That Cut Attacks Hailed As 'huge Deal'
Alzheimer disease (AD) is a type of dementia that affects memory, thinking, language and behavior. Increasing age and high number of people suffering from Alzheimer's with age 65 and older are the major risk factors for progression of this disorder. It starts with mild symptoms and ends with severe brain damage in which individuals lose the ability to carry on a conversation and respond to their environment. According to Alzheimer
Alzheimer Diagnostic Tests Market - Medical Devices Pipeline Assessment, 2017 | …
"The Latest Research Report Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Alzheimer Diagnostic Tests Market GlobalData's Medical Devices sector report, Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Alzheimer Diagnostic Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,
Global Alzheimer Market Report: 2015 Edition | Now Available at Researchmoz.us
Researchmoz added Most up-to-date research on "Global Alzheimer Market Report: 2015 Edition" to its huge collection of research reports. Alzheimer’s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such as